Although traditionally considered a very aggressive lymphoma, two indolent variants are now recognized [2]: in situ mantle cell neoplasia and leukemic, non-nodal mantle cell lymphoma (SOX11 negative), which shows a high prevalence of splenic involvement. This evidence concerns the gene SOX11 and mantle cell lymphoma.